Latest market price
30.96
+0.53+1.74%
News
Up 1.7% — OrthoPediatrics to Participate in Upcoming Conferences (globenewswire.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -1.43 | Insider Own | — | Shs Outstand | 26.11M | Perf Week | 26.69% |
| Market Cap | 794.54M | Forward P/E | — | EPS next Y | -0.79 | Insider Trans | -5.30% | Shs Float | 18.20M | Perf Month | 37.32% |
| Enterprise Value | 848.54M | PEG | — | EPS next Q | -0.22 | Short Float | 5.37% | Perf Quarter | 45.74% | ||
| Income | -34.00M | P/S | 3.00 | EPS this Y | — | Short Ratio | 4.58 | Perf Half Y | 92.84% | ||
| Sales | 265.00M | P/B | 2.34 | EPS next Y | — | ROA | -6.66% | Short Interest | 977.33K | Perf YTD | 71.34% |
| Book/sh | 12.98 | P/C | 18.06 | EPS next 5Y | — | ROE | -9.91% | 52W High | 32.62 -5.09% | Perf Year | 84.76% |
| Cash/sh | 1.69 | P/FCF | 198.64 | EPS past 3/5Y | — | ROIC | -4.88% | 52W Low | 14.42 114.70% | Perf 3Y | 29.32% |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | 24.60% 27.15% | Gross Margin | 73.76% | Volatility | 9.48% 4.86% | Perf 5Y | -53.92% |
| Dividend TTM | — | EV/Sales | 3.20 | EPS Y/Y TTM | — | Oper. Margin | -8.38% | ATR (14) | 1.39 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 2.00 | Sales Y/Y TTM | 16.74% | Profit Margin | -12.83% | RSI (14) | 74.90 | Recom | 2.07 |
| Dividend Gr. 3/5Y | — | Current Ratio | 4.55 | EPS Q/Q | 4.17% | SMA20 | 24.35% | Beta | 0.88 | Target Price | 30.29 |
| Payout | 0.00% | Debt/Eq | 0.29 | Sales Q/Q | 19.67% | SMA50 | 29.94% | Rel Volume | 1.75 | Prev Close | 30.43 |
| Employees | 602 | LT Debt/Eq | 0.29 | Earnings | Feb 25 | SMA200 | 55.10% | Avg Volume | 278.96K | Price | 30.96 |
| IPO Date | Oct 13, 2017 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -7.33% 6.08% | Net Debt/EBITDA | 27.00 | Volume | 488,128 | Change | 1.74% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-28-26 | Reiterated | Needham | Buy | $26 → $35 |
| Oct-28-26 | Reiterated | Stifel Nicolaus | Buy | $20 → $27 |
| Oct-28-26 | Reiterated | Piper Sandler | Overweight | $25 → $30 |
| Oct-28-26 | Reiterated | BTIG | Buy | $29 → $30 |
| Oct-28-26 | Reiterated | Canaccord Genuity | Buy | $25 → $30 |
| Oct-28-26 | Reiterated | Lake Street | Buy | $34 → $38 |
| Aug-20-26 | Reiterated | BTIG | Buy | $23 → $29 |
| Aug-05-26 | Reiterated | Truist Financial | Hold | $20 → $22 |
| Aug-05-26 | Reiterated | Piper Sandler | Overweight | $22 → $25 |
| May-01-26 | Reiterated | Truist Financial | Hold | $20 → $17 |
Latest News· Times ET
Nov-02-26
Oct-30-26
Oct-28-26
12:00AM
OrthoPediatrics Corp. (KIDS) Q3 2026 Earnings Call Transcriptseekingalpha.com
Oct-27-26
08:05PM
OrthoPediatrics Q3 Earnings Call Highlightsmarketbeat.com
07:21PM
04:05PM
04:05PM
08:00AM
Oct-23-26
Oct-23-2608:55AM
Oct-22-26
Oct-22-2612:17PM
Oct-19-26
Oct-19-2608:14AM
Oct-13-26
Oct-13-2604:05PM
09:42AM
Company
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 265 | 236 | 205 | 149 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 69 | 64 | 56 | 37 | — | — | — | — | — | |
| Gross Profit | 194 | 173 | 149 | 111 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 206 | 193 | 167 | 126 | — | — | — | — | — | |
| Research and Development | 8 | 9 | 11 | 11 | — | — | — | — | — | |
| Other Operating Expense | 3 | 0 | 0 | 1 | — | — | — | — | — | |
| Operating Income | -22 | -29 | -30 | -27 | — | — | — | — | — | |
| Interest Expense | 10 | 6 | 3 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -1 | -4 | -10 | 5 | — | — | — | — | — | |
| Net Income Before Taxes | -34 | -39 | -42 | -21 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | -4 | 0 | — | — | — | — | — | |
| Consolidated Net Income | -34 | -40 | -38 | -21 | — | — | — | — | — | |
| Net Income From Continuing Operations | -34 | -40 | -38 | -21 | — | — | — | — | — | |
| Net Income | -34 | -40 | -38 | -21 | — | — | — | — | — | |
| EPS (Recurring) | -1.43 | -1.69 | -1.64 | -0.92 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -1.43 | -1.69 | -1.64 | -0.92 | — | — | — | — | — | |
| EPS (Diluted) | -1.43 | -1.69 | -1.64 | -0.92 | — | — | — | — | — | |
| EBITDA | 2 | -12 | -20 | -8 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.80 | 1.73 | 2.60 | 5.02 | — | — | — | — | — | |
| Gross Margin | 73.21 | 73.31 | 72.68 | 74.50 | — | — | — | — | — | |
| Operating Margin | -8.30 | -12.29 | -14.63 | -18.12 | — | — | — | — | — | |
| Net Margin | -12.83 | -16.95 | -18.54 | -14.09 | — | — | — | — | — | |
| Shares Outstanding | 24 | 23 | 23 | 23 | — | — | — | — | — | |
| Market Capitalization | 743 | 408 | 533 | 748 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Squadron Capital LLC | 10% Owner | Sep 10 '26 | Sale | 21.01 | 302,369 | 6,352,773 | 6,201,764 | Sep 11 |
| Pritzker Jennifer N. | 10% Owner | Sep 10 '26 | Sale | 21.01 | 302,369 | 6,352,773 | 6,201,764 | Sep 11 |
| Pelizzon David R | Director, 10% Owner | Sep 10 '26 | Sale | 21.01 | 302,369 | 6,352,773 | 6,201,764 | Sep 10 |
| Squadron Capital LLC | 10% Owner | Sep 02 '26 | Sale | 23.35 | 22,500 | 525,375 | 6,504,133 | Sep 04 |
| Pritzker Jennifer N. | 10% Owner | Sep 02 '26 | Sale | 23.35 | 22,500 | 525,375 | 6,504,133 | Sep 04 |
| Pelizzon David R | Director, 10% Owner | Sep 02 '26 | Sale | 23.35 | 22,500 | 525,375 | 6,504,133 | Sep 04 |
| Squadron Capital LLC | 10% Owner | Sep 01 '26 | Sale | 23.10 | 10,131 | 234,026 | 6,526,633 | Sep 01 |
| Pritzker Jennifer N. | 10% Owner | Sep 01 '26 | Sale | 23.10 | 10,131 | 234,026 | 6,526,633 | Sep 01 |
| Pelizzon David R | Director, 10% Owner | Sep 01 '26 | Sale | 23.10 | 10,131 | 234,026 | 6,526,633 | Sep 01 |
| Pritzker Jennifer N. | 10% Owner | Aug 28 '26 | Sale | 23.04 | 326,700 | 7,527,168 | 6,536,764 | Sep 01 |
| Pelizzon David R | Director, 10% Owner | Aug 28 '26 | Sale | 23.04 | 326,700 | 7,527,168 | 6,536,764 | Sep 01 |
| Squadron Capital LLC | 10% Owner | Aug 28 '26 | Sale | 23.04 | 326,700 | 7,527,168 | 6,536,764 | Sep 01 |
| Pelizzon David R | Director, 10% Owner | Aug 26 '26 | Sale | 24.28 | 18,000 | 437,040 | 6,863,464 | Aug 26 |
| Pritzker Jennifer N. | 10% Owner | Aug 26 '26 | Sale | 24.28 | 18,000 | 437,040 | 6,863,464 | Aug 26 |
| Squadron Capital LLC | 10% Owner | Aug 26 '26 | Sale | 24.28 | 18,000 | 437,040 | 6,863,464 | Aug 26 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.